In a significant move aimed at bolstering its position as a global pharmaceutical and life sciences hub, the Telangana government has announced plans to establish ten “Pharma Villages” across the state. These integrated Greenfield projects, developed as part of the government’s ambitious “Mega Master Plan-2050,” will attract an estimated investment of ₹1 lakh crore and are expected to create around 5 lakh jobs. The initiative will initially focus on three districts: Vikarabad, Medak, and Nalgonda, with additional sites considered in Mahabubnagar, Rangareddy, Medchal-Malkajgiri, Sangareddy, Siddipet, and Yadadri-Bhuvanagiri.
Strategic Locations for Pharma Villages
The Pharma Villages will be situated within a 90-minute drive from Hyderabad International Airport, ensuring proximity to logistics hubs. Spanning areas between 1,000 and 3,000 acres, the villages will be well-connected by 14 radial roads leading to the Outer Ring Road (ORR) and major national highways, enhancing connectivity to rural and urban regions. This strategic placement aims to integrate rural communities into Telangana's growing industrial landscape and provide employment, healthcare access, and infrastructure development in these areas.
A Hub for Decentralized Biopharma Manufacturing
The decentralized manufacturing model envisioned by Telangana’s Pharma Villages is in line with a global trend of spreading industrial activities across multiple locations. By situating production facilities in rural areas, companies can manage resources more efficiently and reduce transportation costs and emissions. Vishal Goel, Managing Director of RX Propellant, a key player in India’s life sciences infrastructure, emphasized that this decentralized approach allows companies to align production with local demand while fostering economic growth in underdeveloped regions.
Telangana’s Dominance in India’s Pharmaceutical Sector
Telangana is a leading force in India’s pharmaceutical industry, producing about one-third of the nation’s pharmaceutical output and contributing nearly 32% of its merchandise exports, valued at ₹36,893 crore in 2023-24. With a strong foundation in life sciences infrastructure and over 800 companies valued at $50 billion, Telangana is home to more than 200 US FDA-approved sites. These factors, combined with its robust R&D capabilities and innovation-driven ecosystem, position the state as a natural choice for hosting Pharma Villages.
Investment-Friendly Policies and Incentives
To make the Pharma Villages initiative more attractive to investors, Telangana has introduced several investor-friendly policies, including the Telangana Industrial Project Approval and Self-Certification System (TG-iPASS) and the Telangana Industrial Development and Entrepreneur Advancement (T-IDEA) scheme. TG-iPASS simplifies the approval process for industrial projects, reducing bureaucratic hurdles, while T-IDEA offers financial incentives such as investment subsidies and power cost reimbursements. Together, these initiatives are expected to draw investment from both established companies and emerging startups in the pharmaceutical sector.
Industry-Academia Collaboration for Innovation
The Pharma Villages initiative also aims to leverage the talent and research expertise of Telangana’s premier educational institutions, fostering industry-academia collaborations that could lead to groundbreaking advancements in life sciences. Universities and research centers in the state will play a pivotal role in supporting companies with skilled talent and new technologies, furthering Telangana’s reputation as a center for pharmaceutical research and development.
Economic Impact and Community Development
The development of Pharma Villages is expected to have a transformative impact on Telangana’s economy, significantly boosting GDP and creating a large number of employment opportunities. By decentralizing the pharmaceutical industry, the state aims to foster economic development in rural areas, bringing with it new schools, hospitals, and a pollution-free environment that benefits local communities.
Moreover, localized production within these Pharma Villages will lead to improved access to healthcare in remote regions, reducing costs and time associated with delivering essential medicines to rural populations. This aligns with the state’s vision of creating a sustainable, inclusive model of industrial growth that benefits both urban and rural areas.
Telangana’s Role in Shaping the Future of Pharma Manufacturing
With the Pharma Villages initiative, Telangana is setting a benchmark in India’s pharmaceutical and life sciences industry, moving towards a model that not only prioritizes economic growth but also focuses on social impact. The initiative showcases the state’s commitment to adopting sustainable practices and creating resilient infrastructure that can adapt to the evolving demands of the global pharmaceutical industry.
Industry leaders are encouraged to view the Pharma Villages as an opportunity to explore the benefits of localized production while remaining competitive on a global scale. As Telangana strengthens its position as a life sciences powerhouse, these Pharma Villages are set to become hubs of innovation, economic growth, and healthcare access, positioning the state at the forefront of India’s pharmaceutical landscape.
Back
